Safety and efficacy of subcutaneous tanezumab in patients with knee or hip osteoarthritis by Birbara C, Dabezies JR EJ, Burr AM, Fountaine RJ, Smith MD, Brown MT, West CR, Arends RH, Verburg KM

Subjects: “…Tanezumab…”
Get full text

Pooled Analysis of Tanezumab Efficacy and Safety with Subgroup Analyses of Phase III Clinical Trials in Patients with Osteoarthritis Pain of the Knee or Hip [Corrigendum] by Tive L, Bello AE, Radin D, Schnitzer TJ, Nguyen H, Brown MT, West CR

Subjects: “…tanezumab…”
Get full text

Time to first and sustained improvement in WOMAC domains among patients with osteoarthritis receiving tanezumab by D.J. Hunter, T.J. Schnitzer, J. Hall, D. Semel, I. Davignon, J.C. Cappelleri, A.G. Bushmakin, L. Abraham

Subjects: “…Tanezumab…”
Get full text

Pooled analysis of tanezumab efficacy and safety with subgroup analyses of phase III clinical trials in patients with osteoarthritis pain of the knee or hip by Tive L, Bello AE, Radin D, Schnitzer TJ, Nguyen H, Brown MT, West CR

Subjects: “…tanezumab…”
Get full text

Clinical Outcomes of Tanezumab With Different Dosages for Patient With Osteoarthritis: Network Meta-Analysis by Rui Hu, Ya-Feng Song, Zhi-Yan Yang, Chao Zhang, Bo Tan

Subjects: Get full text

Pathogenetic role of the pain threshold Hypothetical therapeutic perspectives based on the use of drugs to elevate it by Guido Orlandini

Subjects: Get full text

Anti-nerve growth factor in pain management: current evidence by Chang DS, Hsu E, Hottinger DG, Cohen SP

Subjects: Get full text

Use of tanezumab for chronic pain treatment by A. E. Karateev, A. M. Lila, L. I. Alekseeva

Subjects: Get full text

Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis by Mona K Patel, Alan D Kaye, Richard D Urman

Subjects: Get full text

Treatment of chronic low back pain – new approaches on the horizon by Knezevic NN, Mandalia S, Raasch J, Knezevic I, Candido KD

Subjects: Get full text

Monoclonal antibodies as analgesia of chronic low back pain: a systematic review and meta-analysis of efficacy and safety by Nobel Budiputra, Charista Lydia Budiputri, Michelle Patricia Muljono

Subjects: Get full text

Observed efficacy and clinically important improvements in participants with osteoarthritis treated with subcutaneous tanezumab: results from a 56-week randomized NSAID-controlled... by Tuhina Neogi, David J. Hunter, Melvin Churchill, Ivan Shirinsky, Alexander White, Ali Guermazi, Masanari Omata, Robert J. Fountaine, Glenn Pixton, Lars Viktrup, Mark T. Brown, Christine R. West, Kenneth M. Verburg

Subjects: “…Tanezumab…”
Get full text

Tanezumab: a selective humanized mAb for chronic lower back pain by Webb MP, Helander EM, Menard BL, Urman RD, Kaye AD

Subjects: “…tanezumab…”
Get full text